MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices by Saunders, W. B.
Introduction
Recent studies have demonstrated that proteinase-mediated
degradation of the supporting extracellular matrix (ECM) is
critical for vascular regression (Bajou et al., 1998; Bajou et al.,
2001; Davis et al., 2001; Davis et al., 2002; Zhu et al., 2000).
Elucidation of the mechanisms regulating vascular regression
is essential for attempts to induce regression of angiogenic
vessels associated with tumors (Browder et al., 2000;
Carmeliet and Jain, 2000; Folkman, 1997; Hanahan, 1997;
Holash et al., 1999) or in diseases such as diabetic retinopathy
or retinopathy of prematurity (Cai and Boulton, 2002;
Campochiaro and Hackett, 2003; Mechoulam and Pierce,
2003). Normally, vascular regression follows angiogenic
responses during wound healing and endometrial shedding
during the menstrual cycle (Ausprunk et al., 1978; Clark, 1996;
Madri et al., 1996). One possibility is that the normal vascular
regression response is inhibited under pathologic conditions
such as that observed within a tumor wound microenvironment
(Davis et al., 2002). Inhibition of vascular regression, as well
as stimulation of new blood vessel formation, may together
explain why tumors show increased vascularity. Vascular
regression inhibitory agents include proteinase inhibitors such
as plasminogen activation inhibitor-1 (PAI-1) and tissue
inhibitor of metalloproteinase-1 (TIMP-1) (Bacharach et al.,
1998; Bajou et al., 2001; Davis et al., 2001; Davis et al., 2002;
Zhu et al., 2000). 
Data from several laboratories suggest that extracellular
matrix stability is required for a proper angiogenic response.
Plasmin directly degrades fibrin, a major ECM substrate for
angiogenesis (Pepper, 2001; Senger, 1996; Vernon and Sage,
1995) and further activates MMP-1, MMP-3, MMP-9 and
MMP-10 (He et al., 1989; Jeffrey, 1998; Lund et al., 1999;
Murphy et al., 1999; Nagase, 1998; Suzuki et al., 1990). The
activated forms of these proteinases promote degradation of
collagen type I, or basement membrane matrices that represent
other important angiogenic substrates (Davis et al., 2002;
Pepper, 2001; Senger, 1996; Vernon and Sage, 1995).
Furthermore, a recent study revealed that decreased plasmin
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Previous work has shown that endothelial cell (EC)-derived
matrix metalloproteinases (MMPs) regulate regression of
capillary tubes in vitro in a plasmin- and MMP-1
dependent manner. Here we report that a number of serine
proteases can activate MMP-1 and cause capillary tube
regression; namely plasma kallikrein, trypsin, neutrophil
elastase, cathepsin G, tryptase and chymase. Plasma
prekallikrein failed to induce regression without
coactivators such as high molecular weight kininogen
(HMWK) or coagulation Factor XII. The addition of
trypsin, the neutrophil serine proteases (neutrophil elastase
and cathepsin G) and the mast cell serine proteases
(tryptase and chymase) each caused MMP-1 activation and
collagen type I proteolysis, capillary tubular network
collapse, regression and EC apoptosis. Capillary tube
collapse is accompanied by collagen gel contraction, which
is strongly related to the wound contraction that occurs
during regression of granulation tissue in vivo. We also
report that proMMP-10 protein expression is markedly
induced in ECs undergoing capillary tube morphogenesis.
Addition of each of the serine proteases described above led
to activation of proMMP-10, which also correlated with
MMP-1 activation and capillary tube regression.
Treatment of ECs with MMP-1 or MMP-10 siRNA
markedly delayed capillary tube regression, whereas
gelatinase A (MMP-2), gelatinase B (MMP-9) and
stromelysin-1 (MMP-3) siRNA-treated cells behaved in a
similar manner to controls and regressed normally.
Increased expression of MMP-1 or MMP-10 in ECs using
recombinant adenoviral delivery markedly accelerated
serine protease-induced capillary tube regression. ECs
expressing increased levels of MMP-10 activated MMP-1 to
a greater degree than control ECs. Thus, MMP-10–induced
activation of MMP-1 correlated with tube regression and
gel contraction. In summary, our work demonstrates that
MMP-1 zymogen activation is mediated by multiple serine
proteases and MMP-10, and that these events are central
to EC-mediated collagen degradation and capillary tube
regression in 3D collagen matrices.
Key words: Matrix metalloproteinase-1, Matrix metalloproteinase-
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generation by breast carcinomas adversely affected prognosis
in patients with breast cancer (Chappuis et al., 2001). These
data support the hypothesis that proteolytic ECM degradation,
or destruction of the angiogenic scaffold, leads to collapse of
angiogenic networks. 
Other studies present a different view, stating that
proteinases such as plasmin and soluble MMPs stimulate
angiogenic responses by promoting basement membrane
degradation and ECM proteolysis necessary for EC invasion
and sprouting (Carmeliet and Jain, 2000; Foda and Zucker,
2001; Pepper, 2001; Sternlicht and Werb, 2001; Werb et al.,
1999; Zucker et al., 2000). Additional work has strongly
implicated membrane-associated MMPs (i.e. MT-MMPs) as
the major contributors to endothelial and epithelial tube
morphogenesis in three-dimensions (Bayless and Davis, 2003;
Davis et al., 2002; Hiraoka et al., 1998; Hotary et al., 2000).
Proteinase inhibitors such as PAI-1 and TIMP-1 (which
primarily block secreted proteinases) have no ability to inhibit
morphogenesis, whereas inhibitors such as TIMP-2 and TIMP-
3 inhibit morphogenic events (Bayless and Davis, 2003; Davis
et al., 2002; Hiraoka et al., 1998). Thus, one of the issues in
capillary tube morphogenesis and regression is the role of
soluble versus membrane-bound MMPs. Our work concerning
plasminogen and MMP-1 dependent capillary tube regression
in collagen matrices in vitro suggests that soluble proteinases
primarily control regression events rather than morphogenic
events (Davis et al., 2001; Davis et al., 2002). This concept,
recently suggested as a new mechanism for vascular
regression, is very similar to findings previously described for
other types of tissue regression (Curry and Osteen, 2001;
Sternlicht and Werb, 2001; Werb et al., 1996; Werb et al.,
1999). Two such examples include mammary gland regression
(Sympson et al., 1994; Talhouk et al., 1992; Werb et al., 1996;
Werb et al., 1999) and uterine endometrial shedding (Curry and
Osteen, 2001; Kokorine et al., 1996; Marbaix et al., 1996).
Thus, degradation of ECM is linked to regression events in the
mammary gland, uterus and vasculature. Determination of the
mechanism by which collagen/ECM degradation might occur
is of central importance in these circumstances.
MMP zymogen activation is an essential step for the
initiation of ECM proteolysis. Proper activation of the
zymogen occurs after pro-peptide cleavage events (Nagase and
Woessner, 1999; Sternlicht and Werb, 2001). Although plasmin
has been described as a key activator of several MMPs, many
other serine proteases (i.e. kallikrein, trypsin, neutrophil
elastase, cathepsin G, tryptase and chymase) have also been
shown to directly activate MMP-1, MMP-2, MMP-3, MMP-9
and MMP-10 in vitro or in vivo (Duncan et al., 1998; Fang et
al., 1997; Gruber et al., 1989; Nagase, 1995; Nagase, 1998;
Okada et al., 1987; Sepper et al., 1997; Shamamian et al., 2001;
Zhu et al., 2001). Stromelysins (i.e. MMP-3 or MMP-10) are
particularly relevant in the context of capillary tube regression
owing to their ability to both degrade various components of
basement membrane matrix such as collagen type IV, laminin
and proteoglycans (Baricos et al., 1988; Bejarano et al., 1988;
Nagase, 1998) and to activate MMPs capable of degrading the
interstitial matrix (MMP-1, MMP-8 and MMP-13) (Knauper
et al., 1996; Nagase, 1998; Nicholson et al., 1989; Windsor et
al., 1993). In addition, it is well known that the serine protease
plasmin and activated stromelysins show synergistic functions
in generating an active form of MMP-1 that is approximately
tenfold more efficient than the enzyme generated by serine
proteases alone (He et al., 1989; Suzuki et al., 1990). For these
reasons, we hypothesized that a member of the stromelysin
family might be involved in the capillary tube regression
response.
Building on our previously described system of EC tubular
morphogenesis and regression (Davis et al., 2001), we
developed a quantifiable micro-well regression assay that is
well suited to study ECM proteolysis in a cell-based system
under serum-free conditions. Using this assay system, we
report that multiple serine proteases activate MMP-1 zymogen,
which leads to capillary tubular network regression in 3D
collagen matrices in an MMP-1 dependent manner. Activation
of EC-derived MMP-1 zymogen caused proteolysis of collagen
type I, capillary tube collapse and collagen gel contraction.
Additionally, we demonstrate for the first time that
stromelysin-2 (MMP-10) zymogen is induced during human
EC tubular morphogenesis in 3D collagen matrices and that
MMP-10 pro-enzyme is activated by the above-mentioned
serine proteases in a manner similar to MMP-1. We further
demonstrate a direct role for both MMP-1 and MMP-10 in the
regression response by inhibiting regression after transfecting
ECs with MMP-1 or MMP-10 siRNAs and showing that tube
regression is markedly accelerated in serine protease-treated
ECs expressing increased levels of MMP-1 or MMP-10. Thus,
activation of MMP-1 zymogen by multiple serine proteases
and MMP-10 leads to collagen matrix degradation, EC
network collapse and gel contraction. Overall, this work
suggests a complementary role for MMP-1, MMP-10 and
serine proteases in controlling vascular tube regression, a key
event in tissue regression responses.
Materials and Methods
Plasma kallikrein, prekallikrein, factor XII and high molecular weight
kininogen were obtained from Enzyme Research Laboratories (South
Bend, IN). Plasminogen was obtained from American Diagnostica
(Stamford, CT). Neutrophil elastase, cathepsin G, tryptase and
chymase were obtained from Calbiochem (La Jolla, CA). Trypsin was
obtained from Boehringer Ingelheim (Germany). The pAdEasy
adenoviral system (He et al., 1998) was kindly provided by Bert
Vogelstein (Johns Hopkins University College of Medicine,
Baltimore, MD). Oligonucleotides were synthesized by Sigma-
Genosys (Woodlands, TX). Recombinant TIMP-1 was obtained from
Chemicon Corp (Temecula, CA). Recombinant PAI-1 was from
Calbiochem. A monoclonal antibody directed to MMP-1 (41-1E5)
used for western blotting was obtained from Oncogene Research
Products (Cambridge, MA). A monoclonal antibody used to detect
MMP-10 (MAB9101) was from R&D Systems (Minneapolis, MN).
A monoclonal antibody used to detect MMP-3 (Clone 4B7.3, product
no. M 6552) was from Sigma (St Louis, MO). Rat tail collagen type
I was prepared as described (Bornstein, 1958).
Human umbilical vein endothelial cells were obtained from
Clonetics (San Diego, CA) and were cultured as described (Maciag
et al., 1979). ECs were used in our experiments from passages 2-6.
The standard EC morphogenesis assay in 3D collagen gels was
performed as described using 3.75 mg/ml of type I collagen (Davis
and Camarillo, 1996; Salazar et al., 1999). The above enzymes were
added at various concentrations to the serum-free culture media
consisting of Medium 199, a 1:250 dilution of the Reduced Serum
supplement II, 50 µg/ml of ascorbic acid, 50 ng/ml phorbol ester, 40
ng/ml recombinant VEGF-165 (Upstate Biochemical, Lake Placid,
NY) and 40 ng/ml FGF-2 (Upstate Biochemical). In the regression
assays using adenoviral infected ECs, phorbol ester was not added.
Journal of Cell Science 118 (10)
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2327MMP-1 is a vascular regression factor
To normalize viral infection, each adenovirus titer was determined
with the Adeno-X Rapid Titer Kit (BD Biosciences, Palo Alto, CA).
For viral infection, 1106 ECs were infected with 2.2107 IFU of
adenovirus. 
Time-lapse photography of individual cultures was performed
at 4 and 10 magnification to demonstrate the capillary tube
regression and gel contraction response. Cultures were fixed following
gel contraction with 3% glutaraldehyde in PBS, pH 7.5 for at least 30
minutes prior to additional manipulation. In some cases, cultures were
stained with 0.1% Toluidine Blue in 30% methanol and then destained
prior to visualization and photography. In other cases, proteinase
inhibitors were added to inhibit collagen proteolysis and gel
contraction. Conditioned media were collected to examine differential
proteinase expression at different times of culture. Conditioned media
were run on 10% SDS-PAGE gels, transferred to PVDF membranes,
and probed and developed as described (Salazar et al., 1999). Three-
dimensional collagen gels were also extracted in some cases to
examine protein expression (Salazar et al., 1999) during the regression
process.
384 micro-well regression assays
To objectively quantify the capillary tube regression and gel
contraction response, we developed a micro-well regression assay in
384-well tissues culture plates. EC cultures were prepared as
described above. For quantitative analysis of gel contraction, 15 µl
mixtures of ECs and collagen matrix (n=8 cultures per condition)
were placed in 384-well tissue culture plates (VWR, West Chester,
PA). Cultures were allowed to equilibrate for 60 minutes prior to
addition of media with or without the described amounts of serine
proteases. Addition of culture media denoted time zero and cultures
were monitored every 4 hours for gel contraction. Upon initiation of
gel contraction, gel area was recorded using an ocular grid and the
percentage of collagen gel contraction was calculated as follows:
[(original area – current gel area)/original area]100. When
contraction was complete, cultures were fixed and media examined as
described above. Data are reported as the mean percentage gel
contraction (±s.d.).
Fluorescent collagenase assay
In order to quantify the collagenase activity of EC cultures, a
commercially available, DQ collagenase assay kit was obtained
(Molecular Probes, Eugene, OR). Conditioned media were collected
at indicated time points and diluted 1:1 in 1 reaction buffer. For each
condition and time point, triplicate samples were incubated overnight
(16-20 hours) at room temperature in 25 µg/ml DQ collagen type I in
black, 96-well plates. Control wells containing DQ collagen and 1
reaction buffer were incubated concurrently to determine background
fluorescence. Collagenase activity was determined by measuring
fluorescence in a Synergy HT fluorescent microplate reader using an
excitation spectra of 485±20 nm and an emission spectra of 528±20
nm. Background fluorescence was subtracted prior to reporting of data
as mean (±s.d.).
Treatment of ECs with MMP-1 siRNA for use in 384 micro-well
regression assay
siGENOME SMARTpool human MMP-1, MMP-2, MMP-3, MMP-9
and MMP-10 siRNAs were obtained from Dharmacon (Lafayette,
CO). α2 macroglobulin and luciferase GL2 duplex siRNA were used
as controls. Confluent ECs were split into 25cm2 flasks at time 0. 6
hours after plating, ECs were washed and transfected with 200 nM
siRNA in antibiotic-free media using 17.5 µl siPORT Amine
(Ambion, Austin, TX). Five hours after transfection, cells were
supplemented with 3 ml antibiotic-free growth media. After 12 hours,
flasks were aspirated, supplemented with fresh, antibiotic-free growth
media and allowed to recover. This transfection procedure was
repeated 48 hours from the time of the first transfection. After the
second transfection, cells were allowed to recover for 28 hours prior
to utilization in the 384 micro-well regression assay. In experiments
using both siRNA and adenoviral-mediated gene transfer, ECs were
infected with adenovirus 24 hours after the second transfection and
3D cultures were established 16 hours later.
Generation of MMP-1, MMP-3 and MMP-10 adenoviruses
Recombinant adenoviruses were constructed containing the full-
length cDNAs for MMP-1, MMP-3 and MMP-10. MMP-1 and MMP-
3 clones were amplified by PCR from endothelial cell cDNA (MMP-
1) and normal human dermal fibroblast cell cDNA (MMP-10) as
described (Bell et al., 2001; Davis et al., 2001; Salazar et al., 1999).
The resulting PCR products were cloned using the indicated
restriction enzymes into the pAdTrack-CMV vector: MMP-1 5′:
AGCTCGAGAGTATGCACAGCTTTCCTCCAC (XhoI) and 5′-AG-
AAGCTTCCATTCAAATTAGTAATGTTCAAT-3′ (HindIII); MMP-
3 5′-AGAGATCTGCCACCATGAAGAGTCTTCCAATCC-3′ (BglII)
and 5′-AGGATATCTCAACAATTAAGCCAGCTGTTAC (EcoRV).
The following primer set was utilized for the construction of full-
length cDNA for MMP-10: 5′-AGAGATCTGCCACCATGATGCAT-
CTTGCATTCC-3′ (BglII) and 5′-AGCTCGAGCTAGCAATGT-
AACCAGCTGTTAC-3′ (XhoI). The clone was amplified from
ATCC vector MGC-1704, which contained the complete coding
sequence for human MMP-10 zymogen. The PCR product was
cloned using the indicated restriction enzymes into the pAdTrack-
CMV vector.
Each pAdTrack-CMV clone was characterized by sequence
analysis prior to recombination with pAdEasy-1 as described (He et
al., 1998). Details of our adenoviral production protocol have been
described previously (Bayless and Davis, 2002). For all constructs,
protein production was verified by western blot analysis. 
Results
Addition of plasma kallikrein to 3D endothelial cell
cultures induces capillary tube regression and collagen
gel contraction
Plasma kallikrein and plasmin have previously been shown to
demonstrate a synergistic influence on inducing the regression
of lactating mammary ducts (Selvarajan et al., 2001). We
previously reported that the addition of plasminogen/plasmin
induced MMP-1 dependent capillary tube regression in our
system of 3D EC tubular morphogenesis in collagen matrices
(Davis et al., 2001). To determine whether plasma kallikrein
affects capillary tube regression in a similar manner to
plasminogen/plasmin, a time-course experiment of kallikrein-
induced capillary tube regression and collagen gel contraction
was performed (Fig. 1). In this experiment, 1 µg/ml of active
kallikrein was added to EC cultures as previously described
(Davis et al., 2001) and the same well was photographed over
time to observe the collagen gel contraction process in round,
4.5-mm-diameter micro-wells (Fig. 1A). In addition, EC
cultures were established in a 384 micro-well (3-mm-square
micro-wells) regression assay (Fig. 1B). Conditioned media
were collected at various time points and western blot analysis
of MMP-1 was performed. The capillary tube regression and
collagen gel contraction response seen in Fig. 1A-B directly
correlated with MMP-1 zymogen activation (Fig. 1C,
arrowheads). In the absence of kallikrein, MMP-1 zymogen
remained inactive and tube regression and gel contraction did
not occur.
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To clearly demonstrate the capillary tube regression
phenomenon of individual EC fields, time-lapse photography
was performed in the absence (Fig. 2A) or presence (Fig. 2B) of
1 µg/ml kallikrein. In the absence of kallikrein, EC vacuole,
lumen and network formation occurred normally (Fig. 2A) as
previously described (Davis et al., 2001; Davis and Camarillo,
1996). ECs cultured in the presence of kallikrein (Fig. 2A)
underwent normal morphogenesis initially, as evidenced by EC
sprouts and vacuoles (arrows). The kallikrein-induced regression
response is characterized by capillary tube and vacuole collapse
(arrowheads), which eventually leads to individual EC rounding,
aggregation, death and capillary tube network retraction and
collapse (Fig. 2B, 29, 36, 47 hours). The capillary tube
regression response is further illustrated in Fig. 2C with
established EC tubular networks. EC cultures were established
in the absence of serine proteases and allowed to undergo tube
morphogenesis and network formation for 48 hours prior to the
addition of 1 µg/ml of active kallikrein. An EC-lined tube (Fig.
2B, arrows, 48.5 hours) is shown undergoing tube regression
(arrowheads, 52, 52.5, 53 hours) as indicated by tube collapse
prior to the onset of overall collagen gel contraction.
To further determine the
concentration effects of active
kallikrein during capillary tube
regression, varying doses of the
activated enzyme were added to ECs
in the 384 micro-well regression
assay (Fig. 3A). Quantification of the
capillary tube regression and gel
contraction response is shown as the
percentage of gel contraction over
time. The addition of active plasma
kallikrein resulted in a marked dose-
and time-dependent activation of
MMP-1 zymogen that directly
correlated with capillary tube
collapse and gel contraction (Fig. 3A). In our previous study,
plasminogen/plasmin-induced capillary tube regression
likewise correlated with MMP-1 zymogen activation and
cleavage of the type I collagen matrix (Davis et al., 2001).
Additionally, we demonstrated in our prior study that
plasminogen/plasmin-induced capillary tube regression led to
time-dependent EC apoptosis, whereas ECs cultured in the
absence of plasminogen did not undergo apoptosis (Davis et
al., 2001). In a similar manner, the addition of kallikrein to EC
cultures induced capillary tube regression, collagen gel
contraction and EC apoptosis. Western blot analysis of ECs
undergoing kallikrein-induced tube regression showed marked
induction of active caspase-3, decreased levels of pro-caspase-
3 and pro-caspase-7, and cleavage of the caspase-3 substrates
gelsolin and α-fodrin compared to control cultures (data not
shown). Addition of the proteinase inhibitors, aprotinin (2900
KIU/ml), TIMP-1 (1 µg/ml) and PAI-1 (2.5 µg/ml), not only
completely blocked the kallikrein-induced tube regression and
collagen gel contraction response (as well as the development
of EC apoptosis), but also inhibited activation of MMP-1
zymogen (not shown). Thus, kallikrein-induced MMP-1
Journal of Cell Science 118 (10)
Fig. 1. Plasma kallikrein induced MMP-
1 activation and contraction of
endothelial tube networks. ECs were
suspended in collagen matrices and
plated in 96-well tissue culture plates
(4.5 mm diameter) (A) or 384 micro-
well plates (3 mm square) (B). Culture
media contained plasma kallikrein at 1
µg/ml. The same culture well was
photographed at the indicated times (in
hours) during the capillary tube
regression and collagen gel contraction
process. (C) Conditioned media were
collected and triplicate cultures were
examined for evidence of capillary tube
regression and collagen gel contraction
(+ indicates occurrence of gel
contraction). Samples were run on SDS-
PAGE gels, blotted to PVDF membranes
and probed with anti-MMP-1 antibodies.
Arrows indicate the position of MMP-1
zymogen and arrowheads indicate
activated MMP-1. Note the absence of
activated MMP-1 (arrowhead) in the
absence of kallikrein. Bar, 500 µm.
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2329MMP-1 is a vascular regression factor
dependent tube regression is inhibited by both serine protease
and MMP inhibitors.
Addition of plasma prekallikrein induces capillary tube
regression only in the presence of Factor XII or HMW
kininogen
It is well known that the EC cell surface is an important
regulator of plasma prekallikrein activation via two pathways,
Factor XII or high molecular weight
kininogen (HMWK) (Colman, 1999;
Kaplan et al., 2001; Mahdi et al., 2002;
Schmaier, 2000; Schousboe, 2001).
Dose-response experiments were
performed with Factor XII zymogen,
which was added to ECs in the 384
micro-well assay in the presence or
absence of prekallikrein. As shown in
Fig. 3B, the addition of Factor XII at
doses as low as 32 ng/ml after 50 hours
of culture induced capillary tube
regression and collagen gel contraction
only in the presence of plasma
prekallikrein at 2 µg/ml. Western blot
analysis of MMP-1 activation revealed
that both Factor XII and prekallikrein
were required to induce MMP-1
activation, which correlated with the
tube regression and gel contraction
response (Fig. 3B). The addition of
Factor XII alone did not induce
regression.
A dose-response experiment with
varying doses of added HMWK was
performed with 2 µg/ml prekallikrein in
the presence of Zn2+, Mn2+ or no added
divalent cations (Fig. 3C). Previous
work has indicated that Zn2+ ions
enhance the ability of HMWK to bind to
the EC cell surface and activate plasma
prekallikrein (Joseph et al., 1996). Here,
in the presence of 10 µg/ml HMW
kininogen, collagen gel contraction
occurred in the presence of prekallikrein
without added divalent cations.
However, at lower doses, the presence of
Zn2+ ions but not Mn2+ markedly
stimulated the ability of HMWK to
induce collagen gel contraction. Doses
of HMW kininogen at 1 µg/ml were
sufficient to induce the regression
response in the presence of both
prekallikrein and Zn2+ ions. Zn2+ ions
in the presence of HMWK and
prekallikrein markedly induced MMP-1
activation, which directly correlated
with capillary tube regression and
collagen gel contraction. Overall, these
data indicate that known physiological
mechanisms to activate plasma
prekallikrein on the EC surface lead to
MMP-1 activation and capillary tube regression.
Activation of MMP-1 correlates with increased EC-
derived collagenase activity during plasma kallikrein-
and plasmin-induced capillary tube regression
Although activation of MMP-1 via western blot analysis
correlated in each case with tube regression and gel
contraction, we assayed conditioned media for total
Fig. 2. Time-lapse photography of plasma kallikrein-induced MMP-1 activation and capillary
tube regression. ECs were suspended in collagen matrices and cultured in the absence or
presence of 1 µg/ml kallikrein. Sequential time-lapse photographs were taken of individual
EC fields at the time in hours denoted in each panel. (A) In the absence of kallikrein, ECs
form sprouts, vacuoles and tubular networks, a process known as morphogenesis. (B) In the
presence of kallikrein, morphogenesis is initiated (arrows); however, capillary tubes and
vacuoles collapse (arrowheads), eventually resulting in individual EC rounding, aggregation
and death. (C) ECs were allowed to undergo morphogenesis and establish EC networks for 48
hours prior to the addition of kallikrein. An EC-lined tube (arrows) is visible undergoing tube
regression (arrowheads) prior to the onset of gel contraction. Bar, 100 µm.
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collagenase activity in a time-course experiment. ECs were
cultured as previously described in the absence or presence of
active plasmin or plasma kallikrein at two doses (0.5 µg/ml and
2.5 µg/ml). Conditioned media were collected at the indicated
time points and were analyzed by western blotting and for
collagenase activity using DQ collagen, a collagen preparation
that emits limited fluorescence in its native, triple helical form,
while emitting a strong fluorescent signal following proteolysis
of the collagen triple helix (Della et al., 1999). Conditioned
media from ECs cultured in the absence of plasmin or
kallikrein (Control) showed minimal collagenase activity (Fig.
4) and western blot analysis of this media indicated that MMP-
1 remained in its zymogen form (arrow). In contrast, the
addition of either active plasmin or plasma kallikrein induced
a marked dose- and time-dependent increase in collagenase
activity that directly correlated with both the degree of MMP-
1 activation visible on western blots (arrowheads) and time to
50% collagen gel contraction. The capillary tube regression
and gel contraction response was determined as in Fig. 3 and
the time to 50% gel contraction is shown above each data set.
Journal of Cell Science 118 (10)
Fig. 3. Quantification of plasma kallikrein- or prekallikrein-mediated MMP-1 activation and capillary tube regression in 3D collagen matrices.
ECs were suspended in collagen matrices and placed in a quantifiable 384 micro-well regression assay (15 µl gels, n=8 gels/condition) as
shown in Fig. 1B. At time zero, media containing varying doses of active plasma kallikrein (A) or 2 µg/ml plasma prekallikrein and varying
doses of Factor XII (B) were added to cultures. Collagen gels were monitored for tube regression and gel contraction over time and percentage
of gel contraction was calculated (see Materials and Methods for details). Conditioned media were collected at 50 hours and analyzed for
MMP-1 expression and activation. (C) ECs were suspended in collagen matrices. Culture media contained prekallikrein at 2 µg/ml, along with
varying concentrations of HMW kininogen as indicated and either no cations or 100 µM ZnCl2 or MnCl2. Triplicate cultures were examined
after 24 hours of culture for evidence of capillary tube regression and gel contraction (indicated by +) and analyzed for MMP-1. For all western
blot analyses, arrows indicate the position of MMP-1 zymogen and arrowheads indicate activated MMP-1.
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2331MMP-1 is a vascular regression factor
Thus, the addition of both plasmin and kallikrein induced a
dose-dependent activation of MMP-1, which led to time-
dependent gel contraction and a corresponding increase in
collagenase activity. 
Multiple serine proteases induce MMP-1 zymogen
activation, tube regression and gel contraction
The abilities of plasmin and plasma kallikrein to activate
MMP-1 zymogen have been well described (Armour et al.,
1984; Nagase et al., 1982; Nagase et al., 1990; Suzuki et al.,
1990). Several other serine proteases (trypsin, neutrophil
elastase, cathepsin G, tryptase and chymase) have been shown
to active MMP zymogens in vitro (Duncan et al., 1998; Fang
et al., 1997; Gruber et al., 1989; Okada et al., 1987; Sepper et
al., 1997; Shamamian et al., 2001; Zhu et al., 2001); however,
the ability of these serine proteases to activate MMP-1
zymogen in the context of tissue regression events is unclear
at present. To address this question, dose-response experiments
were performed using the purified serine proteases described
above in the 384 micro-well regression assay. Addition of each
serine protease resulted in a dose-dependent activation of
MMP-1 (data not shown), which directly correlated with the
time to initiation and completion of the tube regression and gel
contraction response (Table 1). This in vitro data provides
evidence that multiple serine proteases, present during
physiologic and pathological vascular regression events in
vivo, are capable of activating MMP-1 and inducing capillary
tube regression and collagen gel contraction in vitro. 
Inhibition of capillary tube regression using an MMP-1
siRNA
In order to directly demonstrate a requirement for MMP-1
(the downstream effector of these serine proteases and the
collagenase responsible for collagen proteolysis) during human
capillary tube regression and collagen gel contraction, ECs were
transfected with MMP-1 siRNA or control siRNAs (luciferase,
α2 macroglobulin). After transfection, ECs were resuspended in
collagen gels in the 384 micro-well regression assay as described
above. Upon completion of gel contraction, media were
collected and western blot analyses were performed (Fig. 5). To
evaluate the effect of decreased MMP-1 protein expression on
the capillary tube regression and gel contraction response, four
different serine protease conditions were added to culture media
(active kallikrein, prekallikrein and Factor XII, neutrophil
elastase, cathepsin G). Transfection of ECs with MMP-1 siRNA
delayed the time to both onset and completion of gel contraction
when compared to control siRNAs when media was
supplemented with active kallikrein (0.5 µg/ml), or prekallikrein
(2 µg/ml) and Factor XII (1 µg/ml) (Fig. 5A). Western blot
analysis of culture media showed a marked decrease in MMP-1
protein levels compared to control cultures in all groups.
Similarly, transfection of ECs with MMP-1 siRNA dramatically
Table 1. Multiple serine proteases are capable of activating
MMP-1, leading to capillary tube regression and collagen
gel contraction
Lowest dose  Time to 50% tube regression (hours)
(µg/ml) inducing Low Intermediate High
Serine protease tube regression dose* dose dose
Trypsin 0.1 34 10 3.5
Neutrophil elastase 0.5 49 25.5 23
Cathepsin G 0.5 37 27 11
Tryptase 0.5 45 24.5 17.5
Chymase 0.5 47.5 29 22
*Low, intermediate and high doses of enzyme were (in µg/ml): 0.1, 0.5 and
2.5 for trypsin; 0.5, 1.0 and 2.5 for neutrophil elastase, cathepsin G, tryptase
and chymase. 
Fig. 4. Activation of MMP-1 correlates with
increased collagenase activity in ECs during
plasma kallikrein- and plasmin-induced capillary
tube regression. ECs were suspended in collagen
matrices and cultured in the absence (Control) or
presence of active plasmin (PL) or kallikrein (Kal)
at two doses (0.5 µg/ml, 2.5 µg/ml). Gels were
monitored for tube regression and gel contraction
via the 384 micro-well regression assay (as in Fig.
3). At the indicated time points, conditioned media
were collected and MMP-1 levels were analyzed
by western blotting. In addition, conditioned media
were analyzed for collagenase activity via the DQ
collagenase assay. Triplicate wells of conditioned
media from the above time points were incubated
with 25 µg/ml of DQ collagen overnight at room
temperature. Absorbance was measured at 528±20
nm via a fluorescent microplate reader.
Background fluorescence was subtracted prior to
reporting of fluorescence in arbitrary units as
mean±s.d. (n=3). Time to 50% gel contraction is
reported above each data set. In each case,
fluorescence corresponded with the degree of
MMP-1 activation on the western blot and the time
to 50% collagen gel contraction. Arrows and
arrowheads indicate the position of MMP-1 in
latent or activated forms, respectively.
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delayed the time to gel contraction when compared to control
siRNAs in the presence of the neutrophil serine proteases,
neutrophil elastase and cathepsin G (data not shown). Again,
western blot analysis of culture media showed a similar decrease
in MMP-1 protein levels in the presence of MMP-1 siRNA
compared to luciferase and α2 macroglobulin (data not shown).
Importantly, treatment of ECs with MMP-1 siRNA had no effect
on the ability of ECs to undergo morphogenesis unlike control
siRNA (Fig. 5B).
MMP-10 zymogen is induced
during EC morphogenesis and is
activated by multiple serine
proteases
In order to investigate whether
additional MMPs are involved in the
capillary tube regression response,
a time course experiment
was performed with ECs during
capillary tube morphogenesis in
collagen matrices as previously
described (Bell et al., 2001; Davis
and Camarillo, 1996). Under
serine protease-free conditions,
conditioned media were collected at
different time points and western
blot analyses were performed to
determine the presence of MMP-3,
MMP-10 or MMP-13 (Fig. 6A).
Although MMP-3 and MMP-13
were not detectable, MMP-10
zymogen was markedly induced and
appeared to remain in its pro-
enzyme form during capillary tube
morphogenesis (Fig. 6A). To
determine the ability of various
serine proteases to activate MMP-
10, dose-response experiments were
performed utilizing ECs suspended
in collagen matrices using the
384 micro-well assay. MMP-10
zymogen was activated in a dose-
dependent manner by plasma
kallikrein (Fig. 6B). Activation of
MMP-10 by kallikrein directly
corresponded with capillary tube
regression and gel contraction
(indicated by +). MMP-10 was also
activated in a dose-dependent
manner by trypsin, neutrophil
elastase, cathepsin G, tryptase and
chymase (data not shown). These
data suggest that MMP-10 may
represent a novel mediator of the
capillary tube regression response.
An MMP-10 siRNA inhibits
capillary tube regression
To determine a role for MMP-10 in
capillary tube regression, ECs were
transfected with an MMP-10 siRNA
as described above. In these experiments, control siRNAs
targeting luciferase (negative control) and MMP-1 (positive
control) were used in addition to siRNAs targeting MMP-2 and
MMP-9 to further evaluate the role of these MMPs. After
transfection, ECs were resuspended in collagen gels in the 384
micro-well regression assay in the presence or absence of
prekallikrein and Factor XII. Western blot analyses of MMP-10
and MMP-1 levels in conditioned media showed a marked
decrease in MMP-10 and MMP-1 protein levels following
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Fig. 5. Treatment of ECs with MMP-1 siRNA decreases MMP-1 protein expression and delays
capillary tube regression and collagen gel contraction. ECs were transfected as described with
MMP-1, α2 macroglobulin (A2Mac), or luciferase control siRNA duplexes at a final concentration
of 200 nM, suspended in collagen matrices and placed in the quantitative 384 micro-well
regression assay (as in Fig. 3). At time zero, culture media was added with or without serine
proteases at the doses indicated and the percentage of gel contraction was calculated over time.
(A) Culture media contained control media, plasma kallikrein, or prekallikrein and Factor XII at
the indicated doses. Upon completion of gel contraction, conditioned media were collected and
analyzed for MMP-1 expression and activation. (B) ECs transfected with the indicated siRNAs
were established in collagen matrices for 46 hours in the absence of serine proteases and were
fixed, stained and photographed. Arrows denote newly established EC vascular networks and open
lumenal structures. Bar, 100 µm.
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siRNA treatment (Fig. 6C). Importantly, both MMP-10 and
MMP-1 siRNAs acted with specificity on their respective targets.
In the presence of prekallikrein and Factor XII, transfection of
ECs with MMP-10 siRNA delayed the time to both onset and
completion of capillary tube regression and gel contraction when
compared to the control (luciferase) (Fig. 6C). Treatment of ECs
with MMP-10 siRNA had no effect on the ability of ECs to
undergo morphogenesis compared to the control (data not
shown), indicating that like MMP-1, MMP-10 is not involved in
the formation of EC networks in 3D collagen matrices. Similar
results were observed when ECs treated with MMP-1 or MMP-
10 siRNAs were cultured in the presence of active kallikrein,
neutrophil elastase, cathepsin G and plasminogen (data not
shown). The capillary tube regression response was not delayed
in ECs treated with MMP-2 or MMP-9 siRNA in the presence
or absence of prekallikrein and Factor XII (Fig. 6C). Overall,
these data provide strong evidence to support a major role for
both MMP-1 and MMP-10 in mediating capillary tube
regression and collagen gel contraction. 
Increased expression of MMP-10 in ECs induces
capillary tube regression and collagen gel contraction
via activation of MMP-1 zymogen
To further define the involvement of MMP-10 (stromelysin-2)
during capillary tube regression, a recombinant adenovirus
encoding the gene for MMP-10 zymogen was generated. ECs
were infected with control virus (GFP Ad) or MMP-10 virus
(MMP-10 Ad) 24 hours prior to initiating cultures in the
absence or presence of the serine proteases kallikrein,
prekallikrein and Factor XII or plasminogen. Cultures were
monitored over time for capillary tube regression and gel
contraction and conditioned media were collected at the
completion of gel contraction for western blot analysis of
MMP-10. ECs infected with MMP-10 adenovirus induced a
rapid capillary tube regression response (Fig. 7A), whereas
ECs infected with control virus (GFP Ad) did not undergo
regression in the absence of serine proteases (data not shown).
Importantly, although each serine protease added to culture
media accelerated regression and gel contraction when
compared to control media, ECs expressing increased levels of
MMP-10 were capable of initiating a regression response in the
absence of any added serine protease. Two possible serine
protease-independent mechanisms of MMP-10 activation
include exposure to free radicals or auto-activation (Nakamura
et al., 1998; Peppin and Weiss, 1986; Tyagi et al., 1993; Tyagi
et al., 1996; Weiss et al., 1985). Confirming this result, western
blot analysis of MMP-10 levels (Fig. 7A) showed minimal
MMP-10 zymogen levels for ECs infected with GFP Ad,
whereas ECs infected with MMP-10 Ad showed markedly
Fig. 6. MMP-10 is induced
during EC morphogenesis, is
activated by serine proteases
and treatment of ECs with
siRNA targeting MMP-10
delays capillary tube
regression and collagen gel
contraction induced by
multiple serine proteases. ECs
were suspended in collagen
matrices as described in the
absence (A) or presence (B) of
varying doses of plasma
kallikrein. Gels were
monitored for contraction
(indicated by +) and
conditioned media were
collected for western blot
analysis of MMP-10 at the
indicated time points (A) or at
72 hours (B). Note that latent
MMP-10 (arrows) is visible in
each condition; however,
active MMP-10 (arrowheads)
is visible only in the presence
of kallikrein. (C) ECs were
transfected as described with
MMP-1, MMP-10, MMP-2,
MMP-9 or luciferase control
siRNA and suspended in
collagen matrices. At time
zero, culture media was added
with or without prekallikrein
(2 µg/ml) and Factor XII (1
µg/ml) and percentage gel
contraction was calculated
over time. Conditioned media were collected and analyzed for MMP-10 or MMP-1 expression and activation, as well as for MMP-2 and MMP-
9 (data not shown). Arrows and arrowheads indicate the latent or activated forms of MMPs, respectively.
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increased levels of both latent (arrows) and active (arrowheads)
MMP-10 regardless of the presence or absence of the described
serine protease.
To investigate these findings, we prepared another
adenoviral vector expressing the related stromelysin, MMP-3
(stromelysin-1). Additional cultures were established using
ECs infected with control virus (GFP Ad) or the adenovirus
encoding MMP-3 zymogen (MMP-3 Ad) 24 hours prior to
addition to the 384 micro-well regression assay (Fig. 7B). Gels
were monitored for contraction and conditioned media
collected as described for Fig. 7A. Similar to increased MMP-
10 expression, ECs infected with MMP-3 Ad induced a rapid
capillary tube regression response (Fig. 7B), whereas ECs
infected with control virus (GFP Ad) did not undergo
regression in the absence of serine proteases (data not shown).
Although each serine protease added to culture media
accelerated regression and gel contraction when compared to
serine protease-free media, MMP-3 infected ECs also were
induced to regress in the absence of any added serine protease
in a manner similar to ECs expressing increased levels of
MMP-10. Western blot analysis of conditioned media showed
no detectable MMP-3 zymogen levels for ECs infected with
GFP Ad, whereas ECs infected with MMP-3 Ad showed
markedly increased levels of both latent (Fig. 7B, arrows) and
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Fig. 7. Increased expression of
stromelysin-2 (MMP-10) and
stromelysin-1 (MMP-3) induce
rapid capillary tube regression
and collagen gel contraction
via activation of MMP-1
zymogen. ECs were infected
with GFP, MMP-10, or MMP-
3 adenoviruses 24 hours prior
to suspension in collagen gels.
Gels were monitored over time
for contraction and conditioned
media were collected at the
completion of the contraction
response. (A) ECs infected
with GFP Ad or MMP-10 Ad
were cultured in control media
or media containing active
kallikrein (0.5 µg/ml),
prekallikrein (2 µg/ml) and
Factor XII (1 µg/ml) (Prekal,
XII), or plasminogen (2 µg/ml)
(Plg). Note that low levels of
MMP-10 were present in GFP
infected cells, whereas cells
infected with MMP-10 Ad had
increased levels of latent
(arrows) and active
(arrowheads) forms of MMP-
10, regardless of the absence or
presence of serine proteases.
Addition of serine proteases
accelerated capillary tube
regression and gel contraction.
(B) ECs infected with GFP Ad
or MMP-3 Ad were cultured in
control media or media
containing kallikrein,
prekallikrein and Factor XII, or
plasminogen at the
concentrations listed in panel
A. No detectable MMP-3 was
present in GFP infected cells,
while cells infected with
MMP-3 Ad had increased
levels of latent (arrows) and active (arrowheads) forms of MMP-3, regardless of the absence or presence of serine proteases. In all cases, the
addition of serine proteases led to more rapid capillary tube regression and gel contraction. (C) ECs infected with GFP Ad or MMP-10 Ad were
cultured in the absence or presence of 0.5 µg/ml kallikrein. Gels were monitored for contraction (indicated by +) and conditioned media were
collected at the indicated time points. Under control conditions, latent MMP-1 (arrows) was present in both GFP and MMP-10 expressing cells,
however, active MMP-1 (arrowheads) was present only in cells expressing increased levels of MMP-10. In the presence of kallikrein, a small
amount of active MMP-1 was present in the GFP-expressing cells, however, the presence of both kallikrein and MMP-10 substantially
increased the amount of active MMP-1, which directly correlated with the time to tube regression and gel contraction.
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active (arrowheads) MMP-3 regardless of the presence or
absence of the described serine protease. To elucidate the
mechanism through which MMP-10 and MMP-3 activation
occurs in the absence of added serine proteases, ECs were
infected with GFP Ad, MMP-10 Ad, or MMP-3 Ad 24 hours
prior to suspension in collagen gels as previously reported
(Davis et al., 2001). Cultures were established in control media
(without serine proteases) in the presence of: aprotinin (5800
KIU/ml), PAI-I (2.5 µg/ml), ecotin (25 µM), AEBSF (100
µM), TIMP-1 (3 µg/ml), α2 macroglobulin (25 µg/ml), or
MMP Inhibitor-I (175 µM). Although regression was inhibited
in the presence of TIMP-1, α2 macroglobulin and MMP
Inhibitor I, regression was not sensitive to serine protease
inhibitors (data not shown), suggesting that either ECs possess
a mechanism to activate stromelysins in a manner that does not
require serine proteases, or that these MMPs can auto-activate
when expressed at sufficiently high levels.
Regulation of capillary tube regression by both MMP-1
and MMP-10 
To determine if MMP-10 induces tube regression and gel
contraction via activation of MMP-1, a time course experiment
was performed utilizing ECs infected with either MMP-10 Ad
or GFP Ad in the absence or presence of 0.5 µg/ml plasma
kallikrein (Fig. 7C). Collagen gels were monitored for tube
regression and gel contraction and conditioned media were
collected at the indicated times. At 24 hours, cultures were
Fig. 8. MMP-1 and MMP-10
regulate EC tube regression in
three dimensional collagen
matrices. (A-C) ECs were
transfected with siRNA against
MMP-1 or luciferase control.
Recombinant adenoviruses
were used 24 hours later to
deliver GFP or MMP-10.
Cultures were established in
the absence (A) or presence of
0.5 µg/ml kallikrein (B) or 2
µg/ml plasminogen (C). Gels
were monitored every 4 hours
for tube regression and percent
gel contraction was recorded.
At 56 hours, cultures were
fixed and conditioned media
were collected for western blot
analysis of MMP-1 levels (A-
C). Note that in all panels a
decrease in latent MMP-1 was
present in cells treated with
MMP-1 siRNA compared to
luciferase control. MMP-1
activation occurred due to an
increase in MMP-10 levels and
also in the presence of the
serine proteases plasma
kallikrein and plasminogen.
(D) ECs were transfected with
siRNA against MMP-10 or
luciferase control as described.
24 hours later, ECs were
infected with GFP-Ad or
MMP-1 Ad. Cultures were
established in the absence or
presence of 2 µg/ml
plasminogen. Cultures were
monitored every 4 hours for
tube regression and percentage
gel contraction was recorded.
At 56 hours, cultures were
fixed and conditioned media
were collected for western blot
analysis of MMP-10 levels. Note that in all cases, a decrease in latent MMP-10 was present in cells treated with MMP-10 siRNA compared to
controls. Arrows and arrowheads indicate the position of MMP-10 in latent or activated forms, respectively.
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fixed and western blot analysis of MMP-1 activation was
performed. Under serine protease-free conditions (control),
ECs expressing GFP produced MMP-1 pro-enzyme (arrows).
Active MMP-1 was detected only in ECs with increased MMP-
10 expression (arrowheads). MMP-1 activation (arrowheads)
correlated directly with the time of tube regression and gel
contraction (indicated by +). In the presence of plasma
kallikrein, activated MMP-1 was observed in ECs expressing
GFP and MMP-10, and as expected, MMP-1 activation was
enhanced (arrowheads) in ECs expressing increased levels of
MMP-10 compared to cells expressing GFP. The presence of
plasma kallikrein increased the amount of active MMP-1 and
accelerated the time to gel contraction when compared to
serine protease-free conditions. This experiment provides
direct evidence that MMP-10 enhances activation of MMP-1,
which directly correlates with tube regression and gel
contraction. 
To further evaluate the ability of MMP-10 to induce tube
regression via activation of MMP-1, ECs were transfected with
MMP-1 or luciferase control siRNA as described above.
Twenty-four hours after the second transfection, ECs were
infected with MMP-10 Ad or control virus (GFP Ad). Sixteen
hours after adenoviral infection, ECs were suspended in
collagen matrices in the 384 micro-well regression assay in the
presence or absence (control) of the serine proteases plasma
kallikrein or plasminogen. Addition of culture media denoted
time zero. At 56 hours, conditioned media were collected for
analysis of MMP-1 levels. ECs induced to express increased
levels of MMP-10 and treated with control siRNA rapidly
induced the tube regression and gel contraction response (Fig.
8A-C, closed boxes), however, ECs with increased expression
of MMP-10 and treated with MMP-1 siRNA had a delayed
tube regression response (open boxes). ECs infected with
control virus (GFP Ad) did not undergo tube regression and
gel contraction during the evaluated time course. The addition
of plasma kallikrein (Fig. 8B) or plasminogen (Fig. 8C) to the
culture medium accelerated the regression response in each
case. Western blot analysis of MMP-1 revealed a marked
decrease in total MMP-1 levels in ECs transfected with MMP-
1 siRNA compared to the control. In the absence of serine
proteases, MMP-1 remained latent in cells expressing GFP, but
was activated by cells expressing increased levels of MMP-10
(Fig. 8A). Thus, MMP-1 siRNA markedly blocked the ability
of increased MMP-10 expression to accelerate tube regression
in ECs.
To provide further support for the dual role of MMP-1 and
MMP-10 in tube regression, ECs were transfected with MMP-
10 or luciferase control siRNA before being infected with
adenoviruses encoding MMP-1 zymogen (MMP-1 Ad) or a
control (GFP Ad) (Fig. 8D). ECs were suspended in collagen
matrices in the 384 micro-well regression assay in the absence
or presence of 2 µg/ml plasminogen. At 56 hours, conditioned
media were collected for analysis of MMP-10 levels. ECs
expressing increased levels of MMP-1 and treated with control
siRNA rapidly induced the tube regression and gel contraction
response at 32-36 hours (Fig. 8D, closed triangles), however,
ECs expressing increased MMP-1 levels and treated with
MMP-10 siRNA underwent delayed tube regression and gel
contraction (open triangles, 40-48 hours). ECs infected with
GFP Ad and treated with control siRNA induced tube
regression at 36-44 hours (closed circles), whereas ECs
infected with GFP Ad and treated with MMP-10 siRNA
exhibited a delayed tube regression response (48-56 hours,
open circles). Western blot analysis of MMP-10 indicated a
marked decrease in MMP-10 levels for cells transfected with
MMP-10 siRNA when compared to control siRNA. These
experiments demonstrate that both EC-derived MMP-1 and
MMP-10 are involved in regulating proteinase-induced
capillary tube regression response in 3D collagen matrices. 
Discussion
MMP-1, MMP-10 and multiple serine proteases regulate
capillary tube regression events in three-dimensional
collagen matrices
Prior reports have shown that proteinases regulate regression
of capillary tubes in vitro (Davis et al., 2001; Davis et al., 2002;
Zhu et al., 2000) and in vivo (Bajou et al., 1998; Bajou et al.,
2001). In contrast, other work has shown that MT-MMPs
(Knauper and Murphy, 1998) in particular, play an important
role in stimulating the formation of capillary tubes in 3D
extracellular matrices (Bayless and Davis, 2003; Davis et al.,
2002; Hiraoka et al., 1998; Hotary et al., 2000). We have
reported that ECs can induce capillary tube regression by
generating the active enzyme plasmin from plasminogen,
which further activates MMP-1 to induce collagen degradation
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Fig. 9. Schematic diagram illustrating the ability of multiple serine
proteases to activate MMP-1 and MMP-10 zymogens to control
capillary tube regression in 3D collagen matrices. MMP-1 is
activated directly by either serine proteases or activated MMP-10
(bold arrow). MMP-10 and serine proteases act synergistically to
super-activate MMP-1, leading to type I collagen degradation,
capillary tube regression and EC apoptosis. MMP-10 contributes to
capillary tube regression by activating MMP-1 zymogen (bold
arrows) and may contribute to degradation of basement membrane
matrix leading also to tube regression and apoptosis (dashed arrow).
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and capillary tube regression (Davis et al., 2001). Here, we
report that multiple serine proteases induce activation of MMP-
1 and MMP-10 to stimulate capillary tube regression. Plasma
kallikrein, trypsin, neutrophil elastase, cathepsin G, tryptase
and chymase have been reported to activate various MMP
zymogens (Armour et al., 1984; Duncan et al., 1998; Fang et
al., 1997; Gruber et al., 1989; Nagase et al., 1982; Okada et
al., 1987; Sepper et al., 1997; Shamamian et al., 2001; Zhu et
al., 2001). In this study, we report that multiple serine proteases
are capable of activating EC-derived MMP-1 and MMP-10
zymogens in a dose-dependent manner. The combination of
serine proteases and active MMP-10 leads to synergistic
activation of MMP-1, which induces collagen proteolysis and
subsequent breakdown of the matrix scaffold supporting
capillary tube networks.
The concept that proteinases mediate capillary tube
regression through ECM degradation is appealing for several
reasons. It is well known that EC survival is dependent on EC-
ECM adhesion, and disruption of these contacts results in EC
apoptosis or anoikis (Frisch and Screaton, 2001; Meredith, Jr
et al., 1993). Furthermore, the matrix scaffold is required for
the integrity of EC-lined tubes in three dimensions (Davis et
al., 2001; Davis et al., 2002; Vernon and Sage, 1995; Zhu et
al., 2000) and physical alterations in this scaffold will cause
tube collapse (Davis et al., 2001). Proteinase-mediated
mechanisms underlie tissue regression phenomena in other
tissues, such as the mammary gland. Werb and colleagues
have shown in pioneering studies that proteinase-induced
degradation of ECM controls mammary gland regression
(Sternlicht and Werb, 2001; Sympson et al., 1994; Talhouk et
al., 1992; Werb et al., 1996; Werb et al., 1999). Furthermore,
plasma kallikrein, plasminogen and MMPs are involved in
these events (Selvarajan et al., 2001; Werb et al., 1996),
showing similar conclusions to the work presented here. Thus,
it appears that proteinase-induced endothelial or epithelial tube
regression is a phenomenon of general importance to tissue
regression. In support of these conclusions, the proteinase
inhibitor RECK knockout mouse resulted in a vascular lethal
phenotype at embryonic day 10.5 (Oh et al., 2001). Analysis
by electron microscopy and immunostaining showed a marked
loss of collagen type I fibrils suggesting that the loss of RECK
resulted in increased interstitial collagenase activity, which
allowed collagen scaffold breakdown and vascular regression.
These in vivo findings from the RECK knockout are
remarkably similar to the in vitro model of collagen proteolysis
and EC tube regression presented here. The nature of the
mouse MMP that might represent the equivalent of human
MMP-1 is not clear at present, but could include MMP-13,
MMP-8, or others (Jeffrey, 1998). Interestingly, we have shown
that adenoviral expression of murine MMP-13 in our EC
culture system markedly accelerates the ability of serine
proteases to induce EC tube regression (W.B.S. and G.E.D.,
unpublished observations). Thus, murine MMP-13 and human
MMP-1 act as pro-regression agents, suggesting that murine
MMP-13 may be capable of serving as the equivalent of human
MMP-1 in regulating mouse capillary tube regression events.
Multiple serine proteases activate MMP-1 zymogen to
regulate capillary tube regression in 3D collagen matrices
All of the serine proteases evaluated in this study caused MMP-
1 activation that led to capillary tube regression. MMP-1, an
interstitial collagenase, is activated in our system to initiate
capillary tube collapse and collagen gel contraction.
Previously, we reported that collagen type I degradation
accompanied this regression response and that EC apoptosis
also occurred during these events (Davis et al., 2001). It is also
important to note that MMP-1, which is of central importance
to the capillary tube regression phenomena presented here, has
been reported to regulate uterine gland regression during the
menstrual cycle (Curry and Osteen, 2001; Kokorine et al.,
1996; Marbaix et al., 1996). MMP-1 has been shown to be
transcriptionally regulated during this cycle and to be induced
just prior to the initiation of gland regression. In this case, both
endometrial and vascular tissue regression correlated with
maximal MMP-1 expression. This work strongly implicates
MMP-1 as a key factor in tissue regression phenomena in
humans. In further support of such findings, a recent study
showed that increased MMP-1 expression in human melanoma
tumors correlated with tumor regression and a better clinical
outcome (Nikkola et al., 2001). MMP-1 has also been reported
to be a positive regulator of tumor invasion and keratinocyte
migration (Benbow et al., 1999; Brinckerhoff et al., 2000;
Dumin et al., 2001; Pilcher et al., 1997; Pilcher et al., 1998).
Thus, MMP-1 and other MMPs appear to stimulate cell
behaviors that are associated with tumor invasion and
progression (Egeblad and Werb, 2002). Our previous work and
the current study describe a new function for MMP-1, which
is to regulate capillary tube regression in 3D ECM
environments (Davis et al., 2001; Davis et al., 2002). The
ability of various serine proteases to initiate MMP activation
leading to collagen and ECM proteolysis and tissue regression
is compelling. It appears that these pathways overlap and act
synergistically to regulate ECM proteolysis. Although this
report focuses on EC capillary tube regression, we believe the
results are relevant to a wide variety of physiological and
pathological conditions. In addition, the data presented in this
study provide strong additional evidence to support a role for
MMP-1 as a vascular regression factor and not as an EC
pro-morphogenesis/invasion factor. Inhibition of MMP-1
expression levels via siRNA dramatically delayed capillary
tube regression and gel contraction, while having no effect on
ECs undergoing tubular morphogenesis (Fig. 5). During the
later stages of wound healing, granulation tissue regresses
and the ECM undergoes wound contraction (Clark, 1996).
Consistent with the findings presented in this study, activation
of MMP-1 during the later stages of wound healing might not
only induce regression of granulation tissue, but also contribute
to wound contraction. In support of this, several studies have
detailed the ability of human fibroblasts and keratinocytes to
contract collagen lattices in an MMP-1 or MMP-13 dependent
manner, respectively (Netzel-Arnett et al., 2002; Pins et al.,
2000).
MMP-10 (Stromelysin-2) is induced during EC
morphogenesis and is activated by multiple serine
proteases, leading to activation of MMP-1 and capillary
tube regression
To our knowledge, this is the first report documenting the
induction of MMP-10 protein during EC tubular
morphogenesis in 3D matrices. The presence of a novel
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stromelysin that remains latent in the absence of serine
proteases, but is activated by multiple serine proteases is
compelling for many reasons. Stromelysins are known to
degrade components of the supporting ECM scaffold, namely
basement membrane molecules such as collagen type IV,
laminin and perlecan (Baricos et al., 1988; Bejarano et al.,
1988; Nagase, 1995; Nagase, 1998). Additionally, it is known
that MMP-10 is capable of activating other MMPs, specifically
interstitial collagenases (MMP-1 and MMP-8), whereas MMP-
3 has been shown to activate MMP-1, MMP-8 and MMP-13.
Importantly, in the presence of serine proteases and
stromelysins, MMP-1 is activated to a ‘super-active’ state with
an approximately tenfold increase in its ability to degrade
collagen (He et al., 1989; Suzuki et al., 1990). Thus, during EC
tube regression and gel contraction, MMP-1 is not only
activated directly by the serine proteases plasmin, kallikrein,
neutrophil elastase, cathepsin G, tryptase and chymase, but is
also activated directly by MMP-10 (Figs 3, 4, Fig. 7C, Table
1). The involvement of MMP-10 in the capillary tube
regression response is shown in Fig. 6. siRNA targeting MMP-
10 dramatically delayed tube regression and gel contraction
in a manner similar to treatment with MMP-1 siRNA.
Interestingly, in this experiment, treatment with MMP-2 or
MMP-9 siRNA did not affect capillary tube regression. MMP-
2 and MMP-9 are capable of degrading denatured collagen as
well as other substrates; but importantly, serine proteases are
also capable of degrading denatured collagens (Chung et al.,
2004; Kapadia et al., 2004). The redundancy in enzymes that
degrade denatured collagen may represent one reason why
siRNA suppression of MMP-2 or MMP-9 expression has no
effect on the tube regression response. Additional evidence
supporting a key role of MMP-10 during tube regression is
provided in Fig. 8. ECs expressing MMP-10 at increased levels
underwent a capillary tube regression response in a manner that
was dependent on MMP-1. 
Thus, our data are consistent with the conclusion that EC-
derived MMP-10 and serine proteases function cooperatively
to activate MMP-1 in order to accomplish proteolysis of
collagen type I, capillary tube regression and collagen gel
contraction (Fig. 9). We present clear evidence that MMP-10
plays a role in MMP-1 activation in that increased expression
of MMP-10 accelerates MMP-1 activation (Fig. 7C) and
siRNA suppression of MMP-10 delays MMP-1-mediated tube
regression and gel contraction (Fig. 6C, Fig. 8D). The influence
of MMP-10 on MMP-1 activation directly correlates with
capillary tube regression. Our data indicate that both MMP-1
and MMP-10 are involved in the capillary tube regression
response in 3D collagen matrices that is stimulated by serine
proteases. MMP-10 may also degrade basement membrane
matrix components such as collagen type IV, laminin and
perlecan, which are critical molecules in the assembly of EC-
derived basement membranes. Importantly, stromal-derived
MMP-3 is also a plausible candidate for contributing to
vascular and other regression events in vivo because of its
ability to degrade basement membrane matrix components and
to synergistically activate MMP-1 with serine proteases.
Further studies are necessary to examine the specific role of
these enzymes in basement membrane degradation during
capillary tube regression events. Thus, MMP-1 and MMP-10
are known to target the two key ECM components responsible
for the establishment and maintenance of vascular tube
networks, namely interstitial collagen type I matrix and the
associated basement membrane matrix directly surrounding
EC-lined tubes (Fig. 9) (Davis et al., 2002). Overall, these data
further define critical molecular mechanisms involved in the
disassembly of EC-lined tubes (i.e. capillary tube regression)
and reveal a prominent role for specific MMPs (MMP-1 and
MMP-10) as well as multiple serine proteases in these events.
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